高级搜索

67例结肠癌DNA倍体和Ag-NOR计数分析对判断患者预后价值的初步探讨

A preliminary study of DNA ploidy and Ag-NOR counts on the prognostic evaluation of 67 patients with colonic cancer

  • 摘要: 对67例结肠癌石蜡包埋组织材料做DNA倍体水平分析和Ag-NOR计数。结果见:DNA二倍体肿瘤5年、7年生存率分别为78.0%(32/41)、39.0%(16/41);非二倍体肿瘤则为26.9%(7/26)、11.5%(3/26)(p<0.01、p<0.05);Ag-NOR计数小于均值(6.9±1.0)组5年、7年生存率为80.0%(28/35)、40.0(14/35),大于均值组则为34.4%(11/32)、15.6%(5/32)(p<0.01、p<0.05)。Ag-NOR计数小于均值组DNA二倍体肿瘤占97.1%(34/35);大于均值组二倍体肿瘤占21.9%(7/32)(p<0.01)。结果表明:DNA倍体水平和Ag-NOR计数具有一致性,可以做为判断结肠癌预后指标。

     

    Abstract: Flow cytometry(FCM) and silver colloid staining technique have special valve for retrospective analyses of the tumors.The DNA ploidy and Ag-NOR counts in 67 paraffin-embeded samples were analyzed,5 or 7-year survival rate was 78.0%(32/41) and 39.0%(16/41) for the patients with DNA diploid tumor,while 26.9%(7/26) and 11.5%(3/26) for the patients with DNA non-diploid trmpr(p<0.O1 and p<0.05 respectively).The survival percentage at 5 or 7 yearswas 80.0%(28/35) and 40.0%(14/35) for the patients with Ag-NOR counts less thaw X±SD=6.9±1.O,while 34.4(11/32) and 15.6%(5/32) for those with Ag-NOR counts more than that(p<0.0l and p<0.05 respectively).DNA ploidy and Ag-NOR counts were closely related to prognostic factors of colonic cancer.DNA diploid was 97.7%(34/35) for the patients with Ag-NOR counts less than the mean of 6.9±1.O,while 21.9%(7/32) for the patients with Ag-NOR counts more than that(p<0.01).These findings suggest that DNA ploidy and Ag-NOR counts be considered as prognostic parameters of colonic cancer.

     

/

返回文章
返回